Publication Date: 2020/06/19
Abstract: This study comprises the development and evaluation of an in-situ gelling liquid dosage form of an anti-hypertensive drug. The anti-hypertensive drug used is Amlodipine Besylate (ADB) a long acting calcium channel blocker used for the management of angina and hypertension; the life-threatening conditions require immediate relief.
Keywords: Amlodipine Besylate, Gastric Retention, Antihypertensive, Calcium Channel Blocker, Sodium Alginate, Optimization
DOI: No DOI Available
PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT20MAY862.pdf
REFERENCES